During the past decade, Columbia University Medical Center, Edward Harkness Eye Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Columbia University Medical Center, Edward Harkness Eye Institute" are "Age-related Macular Degeneration" (1 trials), "Central Serous Retinopathy" (1 trials), "Choroidal Ischemia" (1 trials), "Retinitis Pigmentosa" (1 trials) and "Vitelliform Macular Dystrophy" (1 trials). Many other conditions were trialed in "Columbia University Medical Center, Edward Harkness Eye Institute" in a lesser frequency.

Most popular intervention types in "Columbia University Medical Center, Edward Harkness Eye Institute" are "Other" (2 trials), "Biological" (1 trials), "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "4D-125 IVT Injection" (1 trials), "Observational" (1 trials), "Ocular Coherence Tomography-Angiography (OCT-A)" (1 trials), "Sildenafil" (1 trials) and "Standard of Care Sildenafil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Columbia University Medical Center, Edward Harkness Eye Institute" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Columbia University Medical Center, Edward Harkness Eye Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Columbia University Medical Center, Edward Harkness Eye Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Columbia University Medical Center, Edward Harkness Eye Institute, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".